High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2

[1]  Deyu Li,et al.  LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma , 2022, Laboratory Investigation.

[2]  Gang Zhou,et al.  Prognostic and predictive value of the hypoxia-associated long non-coding RNA signature in hepatocellular carcinoma. , 2022, Yi chuan = Hereditas.

[3]  Jinhua Dong,et al.  Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia , 2021, Oncology letters.

[4]  Q. Li,et al.  Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3β pathway , 2021, Clinical and Translational Oncology.

[5]  Xuejing Song,et al.  Long non-coding RNA SNHG3 promotes the development of non-small cell lung cancer via the miR-1343-3p/NFIX pathway , 2021, International journal of molecular medicine.

[6]  W. Hou,et al.  Study on the Effects of miR-490-3p on the Malignant Biological Behavior of Lung Tumor Cell A549 and Its Molecular Mechanism , 2021, Journal of Biomaterials and Tissue Engineering.

[7]  Wei Zhu,et al.  Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis , 2021, Oncology letters.

[8]  Xiaofei Zheng,et al.  LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation. , 2021, Journal of biochemistry.

[9]  N. Lou,et al.  High-mobility group box 2 reflects exacerbated disease characteristics and poor prognosis in non-small cell lung cancer patients , 2021, Irish Journal of Medical Science (1971 -).

[10]  Liang Wang,et al.  Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression , 2021, Journal of experimental & clinical cancer research : CR.

[11]  C-M Liu,et al.  MicroRNA-99b inhibits NSCLC cell invasion and migration by directly targeting NIPBL. , 2021, European Review for Medical and Pharmacological Sciences.

[12]  Xun Lu,et al.  Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular Carcinoma , 2020, J. Comput. Biol..

[13]  C. Dong,et al.  LncRNA SNHG1 promotes the development of oral cavity cancer via regulating the miR-421/HMGB2 axis. , 2020, Cellular and molecular biology.

[14]  Yan Zhou,et al.  IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH , 2020, European journal of histochemistry : EJH.

[15]  Sheng Yang,et al.  MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma , 2020, Cancer management and research.

[16]  Yuan Yao,et al.  LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis. , 2020, Oral diseases.

[17]  Song Yang,et al.  MiR-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway. , 2020, The Journal of surgical research.

[18]  Lian-tang Wang,et al.  High mobility group box 2 modulates the progression of osteosarcoma and is related with poor prognosis , 2020, Annals of translational medicine.

[19]  D. Pei,et al.  Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge , 2020, Journal of Experimental & Clinical Cancer Research.

[20]  Zhi-ye Zhang,et al.  CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis , 2020, Scientific Reports.

[21]  Zhi-ye Zhang,et al.  CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis , 2020, Scientific Reports.

[22]  W. Lei,et al.  TSN inhibits cell proliferation, migration, invasion and EMT through regulating miR-874/HMGB2/β-catenin pathway in gastric cancer. , 2020, Neoplasma.

[23]  A. Lampis,et al.  MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside , 2020, Targeted Oncology.

[24]  Wenxin Qin,et al.  circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D , 2020, Journal of Experimental & Clinical Cancer Research.

[25]  Z. Dong,et al.  Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis. , 2020, Cancer biotherapy & radiopharmaceuticals.

[26]  J. Brosseau.  Regulations on Messenger RNA: Wires and Nodes. , 2020, Advances in experimental medicine and biology.

[27]  Jingjing Xie,et al.  Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer , 2019, Journal of cellular physiology.

[28]  Hongyan Zhang,et al.  Identification of lung-adenocarcinoma-related long non-coding RNAs by random walking on a competing endogenous RNA network. , 2019, Annals of translational medicine.

[29]  Songshu Meng,et al.  PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway , 2019, EBioMedicine.

[30]  Wen-jie Chen,et al.  An autophagy‐related long non‐coding RNA signature for glioma , 2019, FEBS open bio.

[31]  Ling Gao,et al.  HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. , 2019, Human pathology.

[32]  Juan Li,et al.  Long noncoding RNA MAPKAPK5‐AS1 promotes colorectal cancer proliferation by partly silencing p21 expression , 2018, Cancer science.

[33]  F. Barlesi,et al.  The clinical utility of tumor mutational burden in non-small cell lung cancer. , 2018, Translational lung cancer research.

[34]  S. Chellappan,et al.  Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer , 2018, Molecular Cancer.

[35]  D. Raben,et al.  The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer , 2018, Clinical Cancer Research.

[36]  Yubin Liu,et al.  MiR‐490‐3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma , 2018, IUBMB life.

[37]  D. Baldwin,et al.  Recent advances in the management of lung cancer , 2018, Clinical medicine.

[38]  Yu-qin Pan,et al.  MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer , 2018, Journal of Cancer.

[39]  Chuanli Ren,et al.  HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer , 2018, Cell Communication and Signaling.

[40]  K. Kerr,et al.  PD-1 blockade in advanced NSCLC: A focus on pembrolizumab. , 2018, Cancer treatment reviews.

[41]  L. Li,et al.  Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer. , 2017, European review for medical and pharmacological sciences.

[42]  Zhen Yang,et al.  Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer , 2017, Acta biochimica et biophysica Sinica.

[43]  Q. Lan,et al.  An immune-related lncRNA signature for patients with anaplastic gliomas , 2017, Journal of Neuro-Oncology.

[44]  Yu Jin,et al.  B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation. , 2016, Iranian journal of immunology : IJI.

[45]  Rui Zhang,et al.  Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling , 2016, Oncotarget.

[46]  Ke Chen,et al.  miR‐490‐5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA , 2015, Biology of the cell.

[47]  Jian Zhang,et al.  Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma , 2015, PloS one.

[48]  Yin-ling Xiu,et al.  MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression. , 2015, Cancer letters.

[49]  Jun Yu,et al.  Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. , 2015, Cancer research.

[50]  Z. Zong,et al.  microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells , 2014, Journal of Ovarian Research.

[51]  Y. Mao,et al.  High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance. , 2013, Neuro-oncology.

[52]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[53]  M. Bustin,et al.  HMG chromosomal proteins in development and disease. , 2007, Trends in cell biology.

[54]  M. Bianchi,et al.  HMG proteins: dynamic players in gene regulation and differentiation. , 2005, Current opinion in genetics & development.

[55]  P. Nordmann,et al.  Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes. , 2003, Molecular biology of the cell.

[56]  A. Travers,et al.  HMG1 and 2, and related 'architectural' DNA-binding proteins. , 2001, Trends in biochemical sciences.

[57]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .